Global Vitamin D Market 2024-2028

Description

List of Tables

The vitamin D market is forecasted to grow by USD 665.32 mn during 2023-2028, accelerating at a CAGR of 7.86% during the forecast period. The report on the vitamin d market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing awareness about importance of vitamin D, increase in number of vitamin d deficiency disorders, and growing geriatric population.

Technavio's vitamin D market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.24%
CAGR	7.86%
Incremental Value	$665.32mn

By Type

Vitamin D3
Vitamin D2

By Product Type

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing e-commerce market as one of the prime reasons driving the vitamin D market growth during the next few years. Also, increasing healthcare expenditure and increasing popularity of vegan and plant-based lifestyles will lead to sizable demand in the market.

The report on the vitamin D market covers the following areas:

Vitamin D market sizing
Vitamin D market forecast
Vitamin D market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vitamin D market vendors that include Abbott Laboratories, Archer Daniels Midland Co., BASF SE, BioTech Pharmacal, Cadila Pharmaceuticals Ltd., Church and Dwight Co. Inc., Dishman Carbogen Amcis Ltd., Fermenta Biotech Ltd., Glanbia plc, GlaxoSmithKline Plc, INLIFE Pharma Pvt. Ltd., Kingdomway Nutrition Inc., Koninklijke DSM NV, Nestle SA, Pfizer Inc., Reckitt Benckiser Group Plc, Sun Pharmaceutical Industries Ltd., TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD, Xiamen Jindawei Group Co. Ltd., Zhejiang Garden Biochemical Hightech Co. Ltd., Zhejiang NHU Company Ltd., Divis Nutraceuticals, and Torrent Pharmaceuticals Ltd.. Also, the vitamin d market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR71902

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global vitamin D market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global vitamin d market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Product Type Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Type Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Vitamin D3 - Market size and forecast 2023-2028
Exhibit 34: Chart on Vitamin D3 - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Vitamin D3 - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Vitamin D3 - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Vitamin D3 - Year-over-year growth 2023-2028 (%)
6.4 Vitamin D2 - Market size and forecast 2023-2028
Exhibit 38: Chart on Vitamin D2 - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Vitamin D2 - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Vitamin D2 - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Vitamin D2 - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Product Type

7.1 Market segments
Exhibit 44: Chart on Product Type - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product Type - Market share 2023-2028 (%)
7.2 Comparison by Product Type
Exhibit 46: Chart on Comparison by Product Type
Exhibit 47: Data Table on Comparison by Product Type
7.3 OTC - Market size and forecast 2023-2028
Exhibit 48: Chart on OTC - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on OTC - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on OTC - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on OTC - Year-over-year growth 2023-2028 (%)
7.4 Rx - Market size and forecast 2023-2028
Exhibit 52: Chart on Rx - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Rx - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Rx - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Rx - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product Type
Exhibit 56: Market opportunity by Product Type ($ million)
Exhibit 57: Data Table on Market opportunity by Product Type ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Canada - Market size and forecast 2023-2028
Exhibit 83: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 BASF SE
Exhibit 107: BASF SE - Overview
Exhibit 108: BASF SE - Business segments
Exhibit 109: BASF SE - Key news
Exhibit 110: BASF SE - Key offerings
Exhibit 111: BASF SE - Segment focus
12.4 BioTech Pharmacal
Exhibit 112: BioTech Pharmacal - Overview
Exhibit 113: BioTech Pharmacal - Product / Service
Exhibit 114: BioTech Pharmacal - Key offerings
12.5 Dishman Carbogen Amcis Ltd.
Exhibit 115: Dishman Carbogen Amcis Ltd. - Overview
Exhibit 116: Dishman Carbogen Amcis Ltd. - Business segments
Exhibit 117: Dishman Carbogen Amcis Ltd. - Key offerings
Exhibit 118: Dishman Carbogen Amcis Ltd. - Segment focus
12.6 Fermenta Biotech Ltd.
Exhibit 119: Fermenta Biotech Ltd. - Overview
Exhibit 120: Fermenta Biotech Ltd. - Business segments
Exhibit 121: Fermenta Biotech Ltd. - Key offerings
Exhibit 122: Fermenta Biotech Ltd. - Segment focus
12.7 Glanbia plc
Exhibit 123: Glanbia plc - Overview
Exhibit 124: Glanbia plc - Business segments
Exhibit 125: Glanbia plc - Key news
Exhibit 126: Glanbia plc - Key offerings
Exhibit 127: Glanbia plc - Segment focus
12.8 GlaxoSmithKline Plc
Exhibit 128: GlaxoSmithKline Plc - Overview
Exhibit 129: GlaxoSmithKline Plc - Business segments
Exhibit 130: GlaxoSmithKline Plc - Key news
Exhibit 131: GlaxoSmithKline Plc - Key offerings
Exhibit 132: GlaxoSmithKline Plc - Segment focus
12.9 Kingdomway Nutrition Inc.
Exhibit 133: Kingdomway Nutrition Inc. - Overview
Exhibit 134: Kingdomway Nutrition Inc. - Product / Service
Exhibit 135: Kingdomway Nutrition Inc. - Key offerings
12.10 Koninklijke DSM NV
Exhibit 136: Koninklijke DSM NV - Overview
Exhibit 137: Koninklijke DSM NV - Business segments
Exhibit 138: Koninklijke DSM NV - Key news
Exhibit 139: Koninklijke DSM NV - Key offerings
Exhibit 140: Koninklijke DSM NV - Segment focus
12.11 Nestle SA
Exhibit 141: Nestle SA - Overview
Exhibit 142: Nestle SA - Business segments
Exhibit 143: Nestle SA - Key news
Exhibit 144: Nestle SA - Key offerings
Exhibit 145: Nestle SA - Segment focus
12.12 Pfizer Inc.
Exhibit 146: Pfizer Inc. - Overview
Exhibit 147: Pfizer Inc. - Product / Service
Exhibit 148: Pfizer Inc. - Key news
Exhibit 149: Pfizer Inc. - Key offerings
12.13 Reckitt Benckiser Group Plc
Exhibit 150: Reckitt Benckiser Group Plc - Overview
Exhibit 151: Reckitt Benckiser Group Plc - Business segments
Exhibit 152: Reckitt Benckiser Group Plc - Key offerings
Exhibit 153: Reckitt Benckiser Group Plc - Segment focus
12.14 TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD
Exhibit 154: TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD - Overview
Exhibit 155: TAI ZHOU HISOU ND PHARMACEUTICAL CO.,LTD - Key offerings
12.15 Torrent Pharmaceuticals Ltd.
Exhibit 156: Torrent Pharmaceuticals Ltd. - Overview
Exhibit 157: Torrent Pharmaceuticals Ltd. - Business segments
Exhibit 158: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibit 159: Torrent Pharmaceuticals Ltd. - Segment focus
12.16 Zhejiang Garden Biochemical Hightech Co. Ltd.
Exhibit 160: Zhejiang Garden Biochemical Hightech Co. Ltd. - Overview
Exhibit 161: Zhejiang Garden Biochemical Hightech Co. Ltd. - Business segments
Exhibit 162: Zhejiang Garden Biochemical Hightech Co. Ltd. - Key offerings
Exhibit 163: Zhejiang Garden Biochemical Hightech Co. Ltd. - Segment focus
12.17 Zhejiang NHU Company Ltd.
Exhibit 164: Zhejiang NHU Company Ltd. - Overview
Exhibit 165: Zhejiang NHU Company Ltd. - Product / Service
Exhibit 166: Zhejiang NHU Company Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations